Is high body mass index (BMI) a factor associated with a high 21-gene recurrence score in estrogen receptor (ER)–positive, ERBB2-negative (formerly HER2 or HER2/neu) breast cancer, especially in younger patients (≤45 years) with breast cancer? The gene discussed is ERBB2; the disease is breast carcinoma.